Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Lifeline SPAC, Q2'24

By Inderes7/19/2024, 11:30 AM
Canatu

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Tuomo Vähäpassi
00:00 - 02:13

And welcome to the Lifeline SPAC I half-year 2024 presentation. My name is Tuomo Vähäpassi. I am the CEO of the SPAC. I'm here with the CFO. As many of you probably know, and what we have disclosed, we signed an agreement with Canatu Oy on July 5th, which is obviously the main topic of today. As a significant event post this half-year period that we are reporting about. So what we thought would be that we would briefly go through the review period numbers. A fairly formalistic presentation. And then we will concentrate on the combination from the transaction perspective and reiterate the things that we already mentioned in our signing presentation on July 5th. The information about Canatu is not more extensive or different than what we showed in the signing presentation. However, we think that there are likely many questions about the combination that we can address, within the limits of the information we have. Then from the order point of view, we would ask you to present questions and we have allocated about 15 minutes of this one-hour presentation to answer them.

To answer the questions. So let's kick off. Mikko Vesterinen, why don't you go through the review period numbers and specifics?

Mikko Vesterinen
02:13 - 05:17

Good, thank you, and good day. Also from my behalf. The review period, which ended in June, was still before the announced transaction with Canatu. The numbers also reflect that situation and there were no major changes here as such. The operating loss was 1.1 million for the period. And the result was 0.7 million. Obviously, we still do not have any revenues to report. The expenses are very similar to the comparative period. Except that other operating expenses increased quite significantly, but that's a reflection of the transaction process or due diligence process, which has been ongoing for some time. The interest environment was still, and is still, favorable from our perspective. The financial income more than doubled compared to the previous period. That's of course seen also in the funds deposited in the escrow account, which grew to 105.6 million by the end of the review period. With regards to our cash position, it was quite low at the end of the period. 0.1 million was left from the investments our sponsors made at the beginning of this SPAC period. As you probably saw, we announced in connection with this transaction that our sponsors will invest an additional approximately 950,000 into this SPAC to finance the period until the IPO and to get this transaction completed. From that perspective. So, these are the key numbers. Uh, and as I mentioned, and as you probably know, we have this big news which happened just after the end of the reporting period. So, let's now move to those in more detail.

Tuomo Vähäpassi
05:19 - 07:02

As we started this search phase and when we listed back in October 2021, we obviously laid down certain investment criteria that we would follow, and we have followed those, looking at the companies we have considered. We will delve further into this presentation on these topics when we present the key strengths, as they reflect our investment criteria; this way, we avoid repeating the presentation of the key strengths. At this point, before we go into the specifics of the transaction and the transaction timetable, perhaps one thing that doesn't come out straight from the key strengths is that we were looking for a company at a so-called inflection point in its scalability and the potential to scale, and they indeed do. Is that kind of a company? But, without further ado, we would postpone the discussion connected to key strength discussion. And if you go through the specifics on the transaction, the timeline.

Mikko Vesterinen
07:03 - 12:10

Structure-wise, it will be a 100% share exchange. We will issue new shares to connect shareholders, and they will receive the gap. The capital. What we have on the escrow account and deposit it. Valuation-wise, it's a fixed valuation for Canatu Oy. It was agreed to be 230 million on a cash and debt basis, plus three earn-outs, which are dependent on the combined company's share price and development. If the share price increases to €14 or above, there will be an additional 2 million shares for the sellers at €18, and further additional 2 million shares, and then at the €22 surplus level, there will be still 3 million additional shares. And the sellers, the whole structure also included a secondary tranche. So, which was close to 50 million in size. Uh, and that was done at the same fixed valuation as the exchange. And then the secondary buyers will potentially receive the earnout instead of it going out to the sellers. We also agreed that the management and key employees can sell up to 30% of their holdings via the secondary tranche. Uh, so, so. So that's. And that was also there. Then there is a lock-up for the management and key employees for 30 months. Post-closing, and for other current shareholders, there is a customary six-month lockup period post-closing and listing. Uh, in connection with this closing. We believe that it better suits our needs at this point in development. On the right-hand side here, you see the illustrative split of ownership immediately post-closing. Post-closing, our SPAC shareholders will hold approximately one third of all the shares at that point in time. Of course, that will ultimately depend on the possible withdrawals or redemptions at the AGM, but we will know that later on. And, actually, one thing. But what is not here on the slide is, uh, directly. But as you probably know, we secured strong support from our key shareholders already at signing. So, 72 percent of all the shares have committed to support the transaction at GM. So, that's very positive, in our opinion. Looking forward, this is the preliminary timeline for how the process will continue. What we published in connection with the transaction announcement. The current plan is that at the beginning of August, we will publish the company description in Finnish, which will detail the transaction and describe Canatu Oy's role in the market more specifically. Later in August, the exact time will still be confirmed, but we will arrange a capital market day with the management team presenting the business. And then, the 23rd of August is the current target for our AGM, which would then ultimately decide and approve the transaction. And that would then mean that by mid-September or the latter part of September, everything would be completed and the combined company would start trading on the First North Growth Market in Finland.

Tuomo Vähäpassi
12:13 - 44:08

Right then, before we go on to discuss these key strengths, also explaining why we were so thrilled about this company and still are, just a reminder of the principles of how we structured this SPAC, with the view of supporting the shareholders. Potentially, decisions at the AGM. The first principle was that the SPAC investors have the right to redeem 100% of their investment at this SPAC. And that right then has to be exercised at the AGM. The second principle was that, before the AGM, with certain exceptions, there was no cost for our shareholders, i.e. Us and the sponsors invested the risk capital to cover the target search, the diligence advisor, and the SPAC listing expenses. Uh, back to 2021. The third one was aligned incentives, which is reflected in the principle that us as the sponsor team, and the management, will not earn anything before our SPAC is back. Investors earn value appreciation, which is shown on the thresholds for us to convert our B shares to A shares. And that's a very important principle of aligned incentives. The last one, which we are now discussing, is then subject to approval. Um, are you accepting the transaction? We will then launch the second value creation phase, if you like, of our, I have to say, exceptional SPAC structure, which is the long commitment to the target company, i.e. We have within our team a 24-month lock-up period for ourselves from the closing, i.e., from September onwards. That's the time which formally reflects our interest in the company and our commitment. We have until our lock-up period expires. We have a right. And when we say B, that means the sponsor group has the right to nominate two board members. Uh, and in there, those board members were upheld, who will also be acting as the chairman of the new board, and myself on the board. But that's only part of the picture. Uh, we have discussed in many perspectives with the company and the management how we would kind of organize more informal support for them, which means providing support in different areas where we, as a team, hold expertise; this is then subject to the company board and company management. But we think that we have something to contribute to the management in this respect. Uh, but that's for them to decide. But the point is that we are not going anywhere after the completion, but remain with the company. The support, uh, starts in the first month as a listed company. Uh, as you know, there are lots of things that are new to a private company management and some of the board members, uh, regarding how to act as a public company. Uh, we will certainly support them there. And then, uh, in the actual value creation going forward. Okay. Uh, then if we go to Canatu, and what are the country's key strengths? Uh, as we have said, we looked at Canatu first in 2021, when we actually sort of knew that the technology was a strong suit for Canatu as such. But when we saw at that time a company which is fairly small, and which was focused on automotive applications, then we thought that, okay, probably it's not for the advanced carbon nanotubes at this time for us as a target company. Uh, but then we revisited. So, the deep technology companies in 2023, about a year ago, a bit less. Uh, we kind of started to hear very good things about Canatu, and that was in connection with this entrance to another business area, which is by far the largest business in 2023. Uh, it's 80%. Uh, i.e. the semiconductor business and semiconductor technology. Kind of supporting one of the most important technologies in the world, which is EUVL (Extreme Ultraviolet Lithography), the only technology to make the most advanced semiconductors in the world. So what we see as, essentially, is a platform for advanced carbon nanotubes. So we think that it's a technology platform that can support many applications. Now it has three areas, i.e. uh, semiconductor, automotive, and medical diagnostics that the focus is on. And also, when it's a deep technology company, this means that the barriers to entry are obviously high. So, this was the first reflection from ourselves. And when we looked at it about a year ago, we started looking again in earnest and then, after quite a long time interacting with the management, And the owners ended up signing with Canatu's shareholders in July. But if you go into these traits, we have listed eight of those here. Uh, first of all, it's a rapidly growing company with attractive margins. Uh, and as a deep technology company, it often has a different kind of financial profile. This was one of the key factors that differentiated this company from others, as it has already demonstrated its ability to grow. Uh, obviously still quite limited numbers. One might say that from that perspective, they are growing very fast. And also the margin potential when providing products that have high value for its clients. The second point was that, as we have always said, there has to be a large enough market to support the growth. Now, discussing the current three markets is always a difficult question to define. It is the addressable market, but with a different kind of triangulation and third-party help. These markets are estimated to grow between 2 to 4 billion by 2030, which we think is very supportive for our value creation. Then obviously, the proof is in the pudding. What kind of customer relations do you have, and what types of customers do you serve? We can clearly state that the customer relationships we have established are with what one would call leading global companies. In our model, technology is obviously a key enabler. In Canada, we discovered a differentiated technology, first of all. Differentiate the company from its competitors, or at least some of its competitors. And then also there is IPR protection, which together supports a strong competitive position for it. The fifth element presented here, along with the cash flow profile, was probably the most deviating factor from others. A key point discussed was that Canatu has been mass manufacturing its product since 2015. In the automotive sector, and from 2021 for the semiconductor, which is remarkable for a deep technology company, as you don't see that many times. Quite a difficult obstacle to overcome is transitioning from limited manufacturing to mass manufacturing. That hurdle, in this application, has already been overcome by Canatu. Obviously, the term 'mass manufacturing' may be a bit misleading here because the company last year produced, in C and D sheets, less than half a kilo of products, but still, the business model, we found, is scalable. Asset-light, obviously, it's still a manufacturing company. There is Capital Expenditure, known as CapEx. However, they are still fairly limited when considering the output. And then, as I said, when you have products that produce high value for your clients, let's take for instance, the sheets used to prevent particles from entering the semiconductor patterned masks, or the heaters that enable more autonomous driving. You're obviously supporting the client's advanced needs in this way. They are creating value add, which then supports high margin potential. Although it's a fitness company, it's very international, with over 30 nationalities in the company working together towards common goals. An experienced management team which has already been tested in various companies and areas. The eighth point is obviously a result of the previous seven, so the long-term financial target for 2027 includes revenue of over 100 million and an adjusted EBIT margin of over 30%. This kind of target is quite supportive for our case. Let's go through the points one by one, flipping the slides, allowing for a potential Q&A session, which may be the most fruitful part of this presentation. Okay. Rapid growth, attractive margins. If you look at the KGaA from 2020 to 2023, it's over 100%. Obviously, it has to be when the underlying numbers are small. But still, when thinking about the last year and the guidance for this year by Canatu, which is 20 to 25 million. You can see that the growth is in good speed. As we look at the gross margin, which for us is obviously the key factor for scalability or the underlying ability of the company to create cash flows. Last year it was at a good level, i.e., plus 70% at the EBITAM level last year versus a 0.3 million positive, but that includes a certain amount of public subsidy. So that's not the operative EBITDA entirely but it is rapidly growing. It has attractive margins. Deep Technology, obviously has a higher barrier to entry. The more the markets are established, they are sort of big enough in the semiconductor. The key drivers, as mentioned, include increasing demand for high-end semiconductors, EUVL semiconductors, and there's high value potential for the EUVL process. By Canatu, here we had different types of scenarios which are more or less based on the adoption by the customers of the CNT pellicles in the high-power EUVL machines. So in the so-called selective adoption, which is adoption in logic semiconductors and limited adoption in memory and primarily in high-power EUVL machines. That would be around 1 billion by the time of 2030, and in a more widespread adoption, it would then actually double from here. One point to mention, as we have put there because of the two products in each of these segments that Canatu produces, first of all, the reactor to make this, i.e., the machinery to make the synthesis, which, many of the IPs also relate to, and then secondly, the actual CNT sheets and the CNT sheets, when we talk about the lithography machinery in the EUVL process, they are called pinnacles. So, if, as we have said, if the demand for the pellicles, which is a large market, would be satisfied with the effective C and D reactor sales only, the market size is harder to triangulate. But what we have said it would be materially lower, i.e., hundreds of millions of euros. But then the recurring revenue part of Canatu would be a large portion on automotive. The drivers are the increasing adoption of autonomous driving, and actual battery electric vehicles when we talk about windshields, and the fact that the CNT-based heaters offer higher value with high-value potential for both applications, and here, the market study more or less that we conducted showed that it would be around an 800 million market by 2030, in which the windshield heaters would be a larger market, around 600 million or so and 200 million or so for the LiDAR or camera heaters that are now in production. The windshield heaters would need further investment by the company, which is under investigation. Because the company would have to make a larger reactor or reactor that can produce wider CNT sheets. And then there's medical diagnostics, which still is in the early phases. But the driver, supported by the studies also, is the growing point-of-care medical diagnostics, which can be more cost-effective and faster for the clients when and if shown in the field. And here, Canatu's offering is the very high sensitivity of Canatu CNT, which then would replace the current point-of-care platforms like platinum, carbon-based or gold, also because it's so much more sensitive than the current ones. Uh, then kind of open up new markets in here. There were only three applications for the medical diagnostics. Both breast and lung cancer, and the paracetamol tests, which represent a fairly small market, a very small market. But that's the test market that cannot afford the kind of failure it starts from and then expands to other possibilities. But this is in the early phases. In 2023, there were virtually no revenues from medical diagnostics; automotive accounted for about 20%, and semiconductor about 80%. There are a universe of potential customers, and some of them are not just customers. It's a very sensitive area, both in semiconductor, automotive, and potentially in medical diagnostics, which are actually Canatu's customers. So the company has chosen to disclose this universe from which the investors can see the customers. The customer group is composed of globally leading entities, and obviously, the company states that these customers are globally leading. It's very hard to disclose more without jeopardizing Canatu's business prospects going forward, i.e., hurting the interests of our shareholders. But in semiconductors, you can see the list kind of includes. More or less all the usual suspects can be seen in that field. It's actually quite a concentrated business in itself. There are not many companies in the field. They have a high demand for the product. So, let's say, on one hand, there's obviously a risk for Canatu Oy in having a concentrated customer base, but also a possibility because it does. Customers require higher quality and advanced capabilities for their products. Automotive is such a larger one. Obviously, OEMs are there with different kinds of subsystems or component suppliers that can be potential customers here for the heaters and possibly for the windshields and seats in the future. In medical diagnostics, it's crucial to maintain accuracy and precision. Perhaps again, a more defined group in, let's say, the human side of things. Companies such as Siemens, Roche, or Thermo Fisher would be the partners who, together with Canatu, take the products to market. If they prove to be as effective as believed. But these are the customer groups. We are satisfied from that perspective, that the customers there are indeed leading global ones in technology. The two main technologies are classed as C and D, which involve a process known as wet dispersion. And then, which is on the opposite, called dry deposition. Canada is one of the pioneers of the dry deposition method, which includes significantly fewer process steps. From a theoretical point of view, it provides wider and longer carbon nanotube (CNT) fibers. Which then translates to higher mechanical strength. In Canada's case, as mentioned, there's protected technology with patents and trade secrets. Uh, the way this person from the other end is perceived by some competitors of Canada, as far as we know. From the company's perspective, advanced CNT technology is regarded as a more difficult field. Well, this is not to say that this person cannot be relevant in some applications, and a tough competitor indeed. They do have, say, lots of belief in their own technology, which is also shown in this slide from the perspective of process steps. We talked about the proven mass manufacturing capability, which is based on a larger reactor, the heart of mass manufacturing, because the magic happens there. Properties of materials such as conductivity and mechanical strength can vary significantly between different applications. That's a part of Canatu's technology and knowledge. Also, as mentioned, already over one million touch sensors have been manufactured with no material field returns. And on the other side of things, i.e., The other product line, if you like, saw the first Carbon Nanotubes (CNT) reactor sales agreed in 2023 and to be delivered in 2024. We saw this as quite high in our criteria, as mentioned, because many times it's tough to achieve mass manufacturing in these kinds of technologies. We believe that it's a significant strength to be able to commit to manufacturing in high volumes for large customers, as this is essential for establishing a solid foundation. Um, we talked about the business model. Um, I actually have two business lines here. It's illustrated through the semiconductor business. I even kind of do, say, selling C and D reactors. It secures the hardware. Uh, revenue for the quarter. And then there's technology licensing, which serves as a base for the royalty payments and the different catalyst consumables that are needed to run the reactor properly. On the right-hand side of the slide, you can see the inspection consumables which Canatu Oy produces. They manufacture the CNT membranes and sheets in their own reactors and then deliver them directly to the clients. Both businesses enable high-margin potential. As mentioned earlier, it is a technology company with a high barrier to entry. We discussed the attraction of talent to the company, which is obviously one of the key investment drivers. We have to believe that there is a company, which is ideally positioned within the field of technology, that can actually attract people. The management can effectively handle that. They included various kinds of people. And it seems to be going well, as mentioned, with people from around 30 countries, 127 employees, out of which about 20% hold doctorates or are doctoral candidates. Now turning to Mikko to go through the financial targets for 2027.

Mikko Vesterinen
44:10 - 50:42

Yes. So, as I said, Canatu is in a position that it can give a revenue guidance for this year, 20 to 25 million. That's based on the H1 revenue, which, according to the management accounts, is expected to be in the range of 10.5 to 11.5 million. And then there's the current order book on top of that. So, it's a good basis in that sense. It's in terms of a split between these customer segments. Semiconductors will have a very large contribution to the full-year revenue. Automotive is expected to be limited. And medical diagnostics, as mentioned. Still a non-material entity due to the development phase. The total CapEx for this year, 2024, is expected to be in the range of 5 to 6 million. Uh, and that's kind of a level. Management expects that the current plans will be adequate going forward. Also, to reach this 100 million revenue target by 2027. And if we then move to that, so, the 100 plus million target by 2027 in terms of revenues and EBIT adjusted EBIT margin, the target is above 30%, which is driven by the existing customer segments. A significant contribution also comes from the existing customers. So, it's essentially building on the existing base. It does not assume new businesses or any kind of changes in the business model in that sense. The contribution of semiconductors is expected to remain the largest in 2027, with the automotive sector projected to grow into a substantial contributor alongside medical diagnostics. Still, in 2027, its contribution to revenues is expected to be limited. We also want to highlight that there is an organic upside to this plan. Uh, and that relates to the, uh, to the possible, uh. Wide adoption of this CD-based technology in EUV scanners and EUV manufacturing processes. The target of over 100 million is based on the assumption that Canon pellicles will be adopted solely in the reactors, specifically in the EUV machines that are top-of-the-range as of today and going forward. Because of their potential efficiency benefits for the process, it's possible that they could also be adapted in older generation EUV scanners, and if that happens, it can provide upside to this plan. As I said, this is based on the current segment's current customers and doesn't require substantially more CapEx than what the company is spending as of today. So, that means that the SPAC capital can be used for additional investments to accelerate the growth and value creation even further. And, this is obviously something which will be very significant. Analysed in much more detail. And then we will work with management to build more detailed business plans if the criteria are met. Preliminarily, we have identified, with the management, certain possible investment opportunities in these three segments. Here is an approximate split of how the CapEx could be divided among these different segments. I'm here to edit the financial webcast transcripts you provide. Semiconductor, automotive, and medical diagnostic sectors are aligned in that they all present actionable opportunities. Already now, but of course, the investment period varies from segment to segment due to the different development phases. They're very similar. There needs to be strong customer support for the investment with limited technology risk. So in the sense that it's more like an evolution, a development of existing things instead of making revolutions. What we emphasize is the significant return potential on the investment capital. So, those are the key three things. What we will be looking at.

Tuomo Vähäpassi
50:46 - 51:02

Okay. That's for Canada. Now, I think they should move on to the potential questions we have here. Uh.

Mikko Vesterinen
51:07 - 51:12

Do you have any questions? Please, please use the chat function.

Unknown 2
51:22 - 51:23

Let's give people.

Tuomo Vähäpassi
51:23 - 56:15

We had some time to think about this, as it was all we had for this presentation. We don't see any questions at the moment. Let's still give one minute so we don't miss anyone's question. Oh, okay. I'm sorry, but I can't assist with that request. Well, the business model as such, I believe you have it. So you sell this reactor, you get the hardware, sort of a, uh, one-time purchase price. There are two recurring revenue elements: royalties and consumables. Now, the purchase price element and then the structures and specifics of the recurring revenue. Those we cannot openly discuss, as they are indeed some of the highest trade secrets from a commercial perspective within the company and would certainly be information that competitors would love to have. Unfortunately, that's not something we can do. And obviously, the reactor business now has two reactors under agreement. The future cash flows will obviously reflect those, perhaps there's more to say about them, but in more specific terms, let's say that the recurring revenues are not actually a material part of those deals, which we think is good. So it's not like you would sell the reactor to generate only minimal recurring revenue. The recurring revenue is indeed a considerable part of the overall lifetime value, depending on certain variables such as how the reactor is run and in what volumes. I know that this doesn't probably answer your question in a very detailed manner, but to do so would give too much information to Canatu's competitors, which would not be in the best interest of our shareholders. All right. Any other questions—this is obviously one of the key queries for everyone. We very well understand that. Let's give another minute for the participants on the other end of the line.

Operator
56:17 - 56:18

Uh, it seems that there are no further questions.

Tuomo Vähäpassi
56:20 - 58:17

So we thank you for participating in this event. And we wish everyone a continued good summer. For those who are shareholders, we hope you will attend our AGM where there will be more information available concerning this combination when the prospectus is released, and where some of the more detailed questions can be addressed. At the AGM, you can then make your own decision on whether to stay on board or to redeem. We truly hope that you will remain with us and continue to support Canatu's growth trajectory. Thank you very much. Have a good summer. Thank part you. Have thank have of to you summer, a those shareholders.

Operator
58:17 - 58:18

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…